Hinge Health, Inc.

Day range

$110.95 – $113.48

Open

$111.69

Prev close

$111.52

Volume

512.61K

Market cap

$9B

Shares out

80.69M

P/E

83.82

P/S

12.50

P/B

26.14

P/FCF

31.34

ROE

31.2%

ROA

13.0%

Debt/Equity

0.00

Div yield

0.00%

As of Oct 23, 2026

• Lease agreementAug 21, 2026

  On August 18, 2026, Hinge Health, Inc. (the "Company") entered into an office lease agreement (the "Lease") with 50 Beale Street LLC, a Delaware limited liability company (the "Landlord"), for approximately 119,278 rentable square feet located at 300 Mission Street, San Francisco, California (the "Premises"). The aggregate estimated base rent payments due over the term of the Lease are approximately $86.0 million. The Lease is anticipated to expire on February 28, 2037, and grants the Company one five-year renewal option and a one-time early termination right effective January 31, 2035.

• Acquisition agreementAug 4, 2026

  The Company announced on August 4, 2026, that it entered into a definitive agreement to acquire Cylinder Health, Inc. (the "Cylinder Acquisition"). The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2026.

• Guidance issuance or updateJun 9, 2026

  On June 9, 2026, Hinge Health, Inc. (the "Company") issued a press release announcing its first Investor Day at Movement and raising guidance for the second quarter 2026 and full year 2026.

• Annual meeting resultsJun 4, 2026

  On June 3, 2026, Hinge Health, Inc. held its 2026 Annual Meeting of Stockholders. The Company's stockholders voted on two proposals at the Annual Meeting... Based on the votes set forth above, each of the nominees, Teddie Wardi and Tyler Sloat, were elected to serve as Class I directors until the Company's 2029 annual meeting of stockholders.

• Equity compensation grantMar 17, 2026

  Pursuant to the Director Compensation Program, Mr. Sloat was granted an initial award of restricted stock units ("RSUs") with a value of $400,000, effective on his Board appointment date, vesting annually over three years following the grant date, subject to continued service. Mr. Sloat has elected to receive these cash fees as RSUs, as permitted by the Director Compensation Program. If Mr. Sloat is serving on the Board as of the date of the annual meeting of the Company's stockholders, he will receive an annual award of RSUs, currently with a value of $200,000 granted on such annual meeting date, beginning at the Company's 2027 annual meeting of stockholders.

Days to cover

3.3

Short interest

6.33M

Avg volume

1.9M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Reasons to Hold Hinge Health Stock in Your Portfolio for Now
  positiveZacks Investment Research· Sep 21, 2026
• A Hinge Health Backer Sold $38.4 Million in Stock After a 101% Run
  neutralThe Motley Fool· Jul 12, 2026
• Digital Health for the Musculoskeletal Care Market: 2026-2032 Outlook | Increasing Investment in Health and Fitness Apps Drives Adoption of Digital Health Solutions for Musculoskeletal Health Tracking
  positiveGlobeNewswire Inc.· Jun 24, 2026
• Is Hinge Health a Stock to Sell After an Insider Sold 50,000 Shares?
  neutralThe Motley Fool· Jun 12, 2026
• Oura's IPO Could Reveal Whether Wellness Tech Is Finally Wall Street-Ready
  negativeBenzinga· May 22, 2026